Age-related Macular Degeneration

• CLINICAL_TRIALS trial_result · 2006-06-21
  Clinical Trial Update: Photodynamic Therapy in Occult-Only Lesions (POOL) [Phase 4]

  Phase 4 clinical trial update on photodynamic therapy for occult-only lesions in age-related macular degeneration; the study sponsored by No…

• CLINICAL_TRIALS research · 2006-05-29
  Clinical Trial Update: A Study to Evaluate Retisert in the Treatment of Patients With the "Wet" Form of Age-Related Macular Degeneration [Phase 2]

  This document summarizes a Phase 2 clinical trial evaluating the Retisert fluocinolone implant for the treatment of wet age-related macular …

• CLINICAL_TRIALS trial_result · 2006-05-04
  Clinical Trial Update: A Clinical Trial to Explore Safety and Efficacy of Different Doses of Pegaptanib Sodium, Compared to Sham, in Patients With Wet AMD. [Phase 2, Phase 3]

  A completed phase 2/3 trial evaluating different doses of pegaptanib sodium versus sham in wet age-related macular degeneration.

• CLINICAL_TRIALS trial_result · 2006-05-03
  Clinical Trial Update: Study of the Safety, Tolerability and Pharmacokinetics of 1 Mg/Eye and 3 Mg/Eye Pegaptanib Sodium in Patients With Exudative Age-Related Macular Degeneration (AMD) [Phase 2, Phase 3]

  Clinical trial update reporting safety, tolerability, and pharmacokinetics results of intravitreal pegaptanib sodium at 1 mg/eye and 3 mg/ey…

• CLINICAL_TRIALS trial_result · 2006-05-03
  Clinical Trial Update: Pegaptanib Sodium on Foveal Thickening in Patients With Exudative Subfoveal Age-Related Macular Degeneration (AMD) [Phase 2]

  Phase 2 trial update on pegaptanib sodium for exudative age-related macular degeneration, focusing on its effect on foveal thickening.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.